The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of interleukin-enhanced factor 2 (ILF2) expression with prognosis and clinico-genomic features in breast cancer (BC).
 
Matias A. Bustos
No Relationships to Disclose
 
Jun Yin
No Relationships to Disclose
 
Pavel Brodskiy
Employment - Caris Life Sciences
 
Irene Kang
Honoraria - Bristol Myer Squibb; Puma Biotechnology
Speakers' Bureau - Puma Biotechnology
 
Stephanie L. Graff
Stock and Other Ownership Interests - HCA Healthcare
Honoraria - Publicis Health
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Lilly; Genentech; Novartis; Novartis (Inst); Pfizer; Seagen (Inst)
Speakers' Bureau - OncLive
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); Daiichi Sankyo (Inst); Dana Farber Cancer Hospital (Inst); Eisai (Inst); Foundation Medicine (Inst); Genentech (Inst); GRAIL (Inst); H3 Biomedicine (Inst); Immunomedics (Inst); Innocrin Pharma (Inst); Lilly (Inst); Merck (Inst); Merus NV (Inst); Novartis (Inst); Odonate Therapeutics (Inst); Polyphor (Inst); Roche (Inst); Seagen (Inst); Sermonix Pharmaceuticals (Inst); Taiho Pharmaceutical (Inst); TapImmune Inc. (Inst)
 
Sarah Sammons
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Foundation Medicine; Novartis; Sermonix Pharmaceuticals
Research Funding - Abbvie; AstraZeneca/MedImmune; Bristol-Myers Squibb; Lilly; Sermonix Pharmaceuticals
 
Richa Dawar
Honoraria - Agendia; Bayer; Targeted Oncology
Consulting or Advisory Role - Agendia; Daiichi Sankyo; Onc Live; Targeted Oncology
 
David Spetzler
Employment - Caris Life Sciences
Stock and Other Ownership Interests - Caris Life Sciences
Honoraria - Caris Life Sciences
Research Funding - Caris Life Sciences
Patents, Royalties, Other Intellectual Property - Caris Life Sciences holds and has pending patents with intellectual property interests relating to health and medicine.
Travel, Accommodations, Expenses - Caris Life Sciences
 
Dave S. B. Hoon
Stock and Other Ownership Interests - Biological Dynamics; Clearbridge Accelerator; Guardant Health
Honoraria - Archer; Castle Biosciences; Invitae
Consulting or Advisory Role - Archer; Castle Biosciences; Chrysalis Biomedical Advisors; Invitae
Speakers' Bureau - Oxford Gene Technology
Research Funding - Merck